Patents by Inventor Marc Mendillo

Marc Mendillo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170037480
    Abstract: In some aspects, the invention relates to Heat Shock Protein-1 (HSF1) gene and HSF1 gene products in tumor stroma. In some aspects, the invention provides methods of tumor prognosis, treatment-specific prediction, or treatment selection, the methods comprising measuring the level of HSF1 expression or HSF1 activation in a sample obtained from the tumor that comprises tumor-associated stromal cells. In some aspects, the invention relates to the discovery that increased HSF1 expression and increased HSF1 activation in tumor-associated stromal cells correlate with poor outcome in cancer. In some embodiments, the methods comprise measuring HSF1 expression or activation specifically in tumor-associated stromal cells. In some embodiments, the methods comprise measuring HSF1 expression or activation specifically in tumor-associated stromal cells and specifically in cancer cells. In some embodiments HSF1 expression or activation is measured using an antibody that specifically binds to HSF1.
    Type: Application
    Filed: April 13, 2015
    Publication date: February 9, 2017
    Inventors: Ruth Scherz-Shouval, Susan Lindquist, Luke J. Whitesell, Sandro Santagata, Marc Mendillo
  • Publication number: 20150241436
    Abstract: In some aspects, the invention relates to Heat Shock Protein-1 (HSF1) gene and HSF1 gene products. In some aspects, the invention provides methods of tumor diagnosis, prognosis, treatment-specific prediction, or treatment selection, the methods comprising assessing the level of HSF1 expression or HSF1 activation in a sample obtained from the tumor. In some aspects, the invention relates to the discovery that increased HSF1 expression and increased HSF1 activation correlate with poor outcome in cancer, e.g., breast cancer. In some aspects, the invention relates to the HSF1 cancer program genes, HSF1 cancer signature set genes, subsets thereof, and uses in tumor diagnosis, prognosis, treatment-specific prediction, treatment selection, or drug discovery, among others.
    Type: Application
    Filed: May 3, 2013
    Publication date: August 27, 2015
    Inventors: Sandro Santagata, Susan Lindquist, Marc Mendillo, Luke J. Whitesell
  • Publication number: 20030027243
    Abstract: The invention provides screening methods for detecting and identifying compounds that bind to fungal specific target proteins and nucleic acids, as well as compounds which, upon binding or otherwise interacting with the target protein, can inhibit fungal growth, a method of preventing or inhibiting fungal growth in culture, a method of preventing or inhibiting fungal growth in a mammal and a method of studying pathogenic mycetes using such nucleic acid and/or protein sequences. Particularly preferred is the inhibition of the fungus Candida albicans.
    Type: Application
    Filed: June 28, 2001
    Publication date: February 6, 2003
    Applicant: Anadys Pharmaceuticals, Inc.
    Inventors: Craig Thompson, Jeffrey Moore, Ed T. Buurman, John Bradley, Thamara Desilva, Sandra Harris, Svetlana Komarnitsky, Marc Mendillo, Daniel Moore, Melissa McCoy, Karen Sanderson, Tariq Haq, Shuhao Zhu, Fan Long, Eugene Davidov